Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) — The “Saudi Arabia Genetic Testing Market, By Region, Competition, Forecast & Opportunities, 2019-2029F” report has been added to ResearchAndMarkets.com’s offering.
The Saudi Arabia Genetic Testing Market was valued at USD 0.27 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 9.75% through 2029.
The surge in awareness regarding the pivotal role of genetic testing in disease prevention, early detection, and personalized treatment strategies serves as a catalyst for market expansion. This heightened awareness is largely propelled by targeted public health campaigns and educational initiatives, fostering a deeper understanding of the benefits of genetic testing among the populace. Moreover, notable advancements in genetic testing technologies, notably next-generation sequencing (NGS) and gene editing methodologies, have significantly enhanced the accessibility, affordability, and efficiency of genetic testing procedures. These technological strides not only streamline testing processes but also contribute to the market’s growth trajectory by making genetic testing more feasible and practical for a broader demographic.
The escalating incidence of cancer, coupled with the imperative need for precision medicine approaches, underpins the growing demand for genetic testing within the oncology domain. The ability to ascertain cancer susceptibility and tailor treatment strategies based on individual genetic profiles emerges as a compelling driver propelling the adoption of genetic testing in oncological practices. Additionally, the rising significance of pharmacogenomic testing, which elucidates individual responses to medications based on genetic variations, is gaining prominence within the healthcare landscape. The advent of personalized medicine, fueled by insights from pharmacogenomics, emerges as a pivotal driver steering the integration of genetic testing into routine healthcare protocols.
Key Market Trends
Increased Demand for Personalized Medicine
Genetic testing is being used to assess an individual’s genetic predisposition to various diseases, including cancer, cardiovascular conditions, and neurodegenerative disorders. This information can inform proactive health measures and early intervention. Pharmacogenomic testing is increasingly employed to determine how an individual’s genetic makeup affects their response to medications. This allows for the selection of the most effective and safe medications for an individual, reducing the risk of adverse reactions. Genetic testing of cancerous tumors helps identify specific genetic mutations driving the cancer. This information is vital for selecting targeted therapies and predicting treatment outcomes.
Genetic testing is used to diagnose and manage rare and inherited diseases. In Saudi Arabia, where certain genetic conditions are more prevalent, this is especially relevant. Couples and expectant parents are increasingly interested in genetic testing to assess the risk of passing on genetic disorders to their children, driving demand for preconception and prenatal genetic testing. Physicians are using genetic information to create customized treatment plans for patients, considering their unique genetic profiles. This can lead to more effective and personalized healthcare. Genetic testing can identify individuals at risk of developing certain diseases. This allows for preventive measures and early disease detection, potentially improving health outcomes.
Segmental Insights
Type Insights
In 2023, the Saudi Arabia Genetic Testing Market largest share was held by Diagnostic Testing segment and is predicted to continue expanding over the coming years. Diagnostic testing is at the core of genetic testing, as it is primarily used to detect and diagnose genetic disorders and diseases. It plays a crucial role in identifying various medical conditions, including inherited genetic diseases, genetic predispositions, and genetic variations associated with diseases. Genetic disorders, including inherited genetic conditions and genetic predispositions to diseases, are prevalent in populations worldwide, including Saudi Arabia. Diagnostic testing is essential for early disease detection and management.
Saudi Arabia, like many countries, has established newborn screening programs that involve diagnostic genetic testing. These programs aim to identify and diagnose genetic and metabolic disorders in newborns, allowing for early intervention and treatment. The high prevalence of newborn screening contributes to the prominence of the Diagnostic Testing segment. Genetic counselling is often accompanied by diagnostic testing, helping individuals and families understand their genetic risks and make informed decisions about their healthcare and family planning. Diagnostic genetic testing is not only used for diagnosis but also for monitoring the progress and management of genetic disorders. Regular testing is important for patients with known genetic conditions to track their health status and response to treatments.
Technology Insights
In 2023, the Saudi Arabia Genetic Testing Market largest share was held by Biochemical Testing segment in the forecast period and is predicted to continue expanding over the coming years. Biochemical testing is a broad category that encompasses a wide range of genetic tests, including metabolic and enzymatic assays, hormone tests, and tests for specific biochemical markers associated with genetic disorders. These tests play a critical role in diagnosing and monitoring various genetic and metabolic conditions, making them a fundamental component of genetic testing. Many countries, including Saudi Arabia, have implemented newborn screening programs that involve biochemical tests.
These programs aim to detect and diagnose genetic and metabolic disorders in newborns, allowing for early intervention and treatment. The high prevalence of newborn screening contributes to the prominence of the Biochemical Testing segment. Biochemical testing is often used to diagnose common genetic disorders like phenylketonuria (PKU), congenital hypothyroidism, and galactosemia.
These conditions require early detection and management, making biochemical testing an essential component of genetic healthcare. Biochemical tests are routinely performed in clinical practice, and they are often the first step in identifying potential genetic issues. As such, they have a broad application and are commonly used by healthcare professionals. Many genetic and metabolic disorders have well-established diagnostic protocols that involve biochemical testing. Physicians are trained to use these tests as part of their diagnostic toolkit.
Regional Insights
The Northern & Central region dominated the Saudi Arabia Genetic Testing Market in 2023. The Northern and Central regions of Saudi Arabia are home to major cities like Riyadh, Jeddah, and Dammam, which have well-established healthcare infrastructure and facilities. These regions typically have more advanced medical centers, hospitals, and laboratories equipped for genetic testing services. The Northern and Central regions have higher population densities compared to other parts of the country.
This results in a larger pool of potential customers for genetic testing services, as well as a higher concentration of healthcare professionals and facilities. These regions are also the economic hubs of the country, with greater economic development and higher income levels. This makes genetic testing more accessible to individuals who can afford such services. Major universities, research institutions, and medical schools are often located in the Northern and Central regions. These institutions may conduct genetic research and offer genetic testing services, contributing to the growth of the market.
Key Market Players
- Anwa Medical Labs
- NoorDX
- Scientific Laboratories Alliance Company
- ELAJ Group
- Genetrack Saudi Arabia
- Johnson & Johnson Services
- OncoDNA
- Baylor Genetics-King Faisal Specialist Hospital – Saudi Diagnostic Limited
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 82 |
| Forecast Period | 2023 – 2029 |
| Estimated Market Value (USD) in 2023 | $0.27 Billion |
| Forecasted Market Value (USD) by 2029 | $0.47 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Saudi Arabia |
Report Scope:
In this report, the Saudi Arabia Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Saudi Arabia Genetic Testing Market, By Type:
- Carrier Testing
- Diagnostic Testing
- New-born Screening
- Predictive & Pre-symptomatic Testing
- Prenatal Testing
- Others
Saudi Arabia Genetic Testing Market, By Disease:
- Sickle Cell Anemia
- Thalassemia
- Huntington’s Disease
- Cancer
- Others
Saudi Arabia Genetic Testing Market, By Technology:
- Cytogenetic Testing
- Biochemical Testing
- Molecular Testing
Saudi Arabia Genetic Testing Market, By Service Providers:
- Clinical & Metabolic Specialists
- Genetic Counsellors
- Diagnostic Laboratories
- Hospitals
Saudi Arabia Genetic Testing Market, By region:
- Eastern
- Western
- Northern & Central
- Southern
For more information about this report visit https://www.researchandmarkets.com/r/vhsc00
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Saudi Arabian Genetic Testing Market
